Edition:
United Kingdom

Catabasis Pharmaceuticals reports third quarter financial results


Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Catabasis Pharmaceuticals Inc :Catabasis Pharmaceuticals reports third quarter 2017 financial results and reviews business progress.Q3 loss per share $0.31.Q3 earnings per share view $-0.33 -- Thomson Reuters I/B/E/S.Catabasis Pharmaceuticals Inc - co's current operating plan provides for cash to fund operations through august 2018​. 

Company Quote

0.624
-0.0184 -2.86%
16 Nov 2018